Health LibraryWeight & Metabolism
⚖️ Weight & Metabolism

Weight Loss Medication Side Effects: What to Expect and How to Manage Them

GLP-1 side effects like nausea, constipation, and fatigue are common but manageable. A practical guide to what happens and what helps.

K

Dr. Tae Y. Kim, DO

May 9, 2026 · 8 min read

You've done the research. You've decided to try a GLP-1 medication for weight loss. And now you want the unfiltered version: what side effects will you actually experience, how bad will they be, and what can you do about them?

This is that guide — honest, practical, and based on clinical data rather than social media horror stories or pharmaceutical company minimization.

The GI Side Effects: Nausea, Vomiting, Diarrhea, Constipation

Gastrointestinal side effects dominate the GLP-1 experience, especially during the dose escalation phase. They're the reason most people who discontinue these medications do so, and they're the side effects you're most likely to encounter.

Nausea

How common: 20-44% of patients in clinical trials, depending on the medication and dose. Semaglutide (Wegovy) causes nausea in about 44% of patients at some point during treatment; tirzepatide (Zepbound) is similar at higher doses.

What it feels like: Usually a low-grade queasiness rather than the severe nausea of stomach flu or food poisoning. Most patients describe it as "I feel a little off" rather than "I'm going to vomit." That said, some patients do experience moderate to severe nausea, particularly during dose escalation.

When it peaks: Typically worst during the first 1-2 weeks at each new dose level. The standard escalation schedule is designed to minimize this — starting at a low dose and gradually increasing gives your body time to adapt.

Management strategies:

  • Eat smaller meals. Large volumes of food on a stomach that's emptying slowly is a recipe for nausea. Five small meals beats three large ones.
  • Avoid high-fat and greasy foods. Fat slows gastric emptying further, compounding the delayed emptying caused by GLP-1 medications.
  • Stay hydrated. Dehydration worsens nausea. Sip water throughout the day rather than chugging large amounts at once.
  • Ginger. Ginger tea, ginger chews, or ginger capsules have modest but real anti-nausea effects supported by multiple studies.
  • Timing adjustments. Some patients find that taking their injection in the evening reduces next-day nausea. Others prefer morning. Experiment.
  • Don't escalate too fast. If nausea is severe at your current dose, staying at that dose for an extra 2-4 weeks before increasing is reasonable and often effective.
  • Ondansetron (Zofran). For significant nausea that doesn't respond to dietary changes, a short course of prescription anti-nausea medication can bridge the gap. Dr. Kim may prescribe this during particularly challenging dose escalations.

The good news: Nausea is usually transient. In clinical trials, the majority of nausea episodes resolved within the first few weeks at each dose level. Most patients who make it through the escalation period report minimal ongoing nausea at their maintenance dose.

Vomiting

How common: Less common than nausea — about 10-15% of patients experience at least one episode. Persistent vomiting is uncommon.

Management: The same strategies that help nausea help prevent vomiting. If you're vomiting regularly (more than once or twice per week), that's a signal to slow down dose escalation or reassess the medication.

Diarrhea

How common: 15-30% of patients, depending on the specific medication.

What it's like: Usually mild — looser stools rather than urgent, watery diarrhea. It tends to improve with time.

Management:

  • Avoid artificial sweeteners (especially sugar alcohols like sorbitol and maltitol), which can worsen diarrhea
  • Fiber can help firm up stools (psyllium husk is well-tolerated)
  • Stay hydrated — diarrhea increases fluid losses
  • If persistent, discuss with your provider. Rarely, dose adjustment is needed.

Constipation

How common: 10-25% of patients. Some patients alternate between diarrhea and constipation as their GI system adapts.

Why it happens: GLP-1 medications slow gastric motility — not just stomach emptying but transit through the entire GI tract. Slower transit means more water absorption from stool, leading to harder, less frequent bowel movements. Combined with reduced food intake (less bulk moving through the system), constipation can become significant.

Management:

  • Increase fiber gradually. 25-35 grams per day from foods and/or supplements. Psyllium husk, chia seeds, and ground flaxseed are good options.
  • Hydrate aggressively. Fiber without adequate water makes constipation worse, not better.
  • Physical activity. Walking, in particular, promotes bowel motility.
  • Magnesium citrate or oxide. These forms of magnesium have a mild osmotic laxative effect and are generally well-tolerated. 200-400 mg at bedtime often helps.
  • Docusate (Colace). A stool softener that makes stools easier to pass without stimulating bowel contractions.
  • MiraLAX (polyethylene glycol). An osmotic laxative that's safe for regular use if needed. Draws water into the colon to soften stool.

When to worry: If you go more than 4-5 days without a bowel movement, or if constipation is accompanied by severe bloating, abdominal pain, or vomiting, contact your provider. Severe constipation can rarely lead to bowel obstruction.

Fatigue and Low Energy

How common: Not formally tracked as a primary endpoint in most trials, but commonly reported in clinical practice. Estimates suggest 10-20% of patients notice significant fatigue.

Why it happens: Three main factors converge:

  1. You're eating significantly fewer calories. Your body is literally running on less fuel.
  2. Rapid metabolic shifts during early weight loss can temporarily affect energy regulation.
  3. If protein intake is inadequate, muscle function may be subtly impaired.

Management:

  • Ensure adequate caloric intake. GLP-1s reduce appetite, but eating too little (below 1,000-1,200 calories) can cause fatigue beyond what's expected.
  • Prioritize protein at every meal (see our article on muscle preservation)
  • Check for nutrient deficiencies — iron, vitamin D, B12, and folate deficiencies can all cause fatigue and may be unmasked by dietary changes
  • Maintain regular physical activity. Counterintuitive, but exercise actually increases energy over time.

Hair Thinning (Telogen Effluvium)

How common: Reported by approximately 5-6% of patients in clinical trials, though real-world rates may be slightly higher.

Why it happens: This isn't caused by the medication directly. It's caused by the physiological stress of significant weight loss. When your body enters a caloric deficit and loses weight rapidly, some hair follicles prematurely shift from the growth phase (anagen) to the resting/shedding phase (telogen). The result is increased shedding that typically begins 2-4 months after the onset of rapid weight loss.

The important context: This happens with any significant weight loss — bariatric surgery, crash dieting, or medication-assisted weight loss. It's not a side effect of semaglutide or tirzepatide specifically.

Management:

  • Adequate protein intake (hair is made of protein — keratin specifically)
  • Consider biotin supplementation (2,500-5,000 mcg daily), though evidence is modest
  • Ensure adequate iron, zinc, and vitamin D levels
  • Be patient — telogen effluvium is self-limiting. Hair typically begins to recover 6-12 months after weight stabilization

Injection Site Reactions

How common: 3-7% of patients report some degree of injection site reaction.

What it looks like: Mild redness, swelling, itching, or a small bump at the injection site. Usually resolves within 24-48 hours.

Management:

  • Rotate injection sites (abdomen, thigh, upper arm)
  • Allow the medication to reach room temperature before injecting
  • Ice the area for a few minutes before injection if reactions are bothersome
  • Contact your provider if reactions are severe, spreading, or accompanied by systemic symptoms

GERD and Acid Reflux

How common: 5-10% of patients report new or worsened reflux symptoms.

Why it happens: Slowed gastric emptying means food sits in the stomach longer, which can increase pressure on the lower esophageal sphincter and promote acid reflux.

Management:

  • Eat smaller meals
  • Avoid eating within 3 hours of lying down
  • Elevate the head of your bed 6-8 inches
  • Limit known reflux triggers (acidic foods, spicy foods, caffeine, alcohol)
  • OTC antacids or famotidine (Pepcid) for breakthrough symptoms
  • If reflux is severe or persistent, your provider may recommend a PPI

Serious but Rare: When to Call Your Doctor

Most GLP-1 side effects are inconvenient but not dangerous. A few, however, require prompt medical attention:

Pancreatitis

Signs: Severe, persistent abdominal pain (often in the upper abdomen, radiating to the back), accompanied by nausea and vomiting. The pain is typically constant rather than crampy and worsens after eating.

Risk: Very rare — clinical trial rates were less than 0.5%. But the consequence is serious enough to warrant awareness.

Action: Stop the medication and seek medical evaluation immediately.

Gallbladder Disease

Signs: Right upper quadrant abdominal pain, especially after eating fatty foods. Pain may be colicky (comes and goes) and may radiate to the right shoulder.

Risk: Elevated during rapid weight loss by any method. GLP-1 trials show a modestly increased rate of gallbladder events.

Action: Medical evaluation. Gallstones may require surgical intervention.

Severe Allergic Reactions

Signs: Difficulty breathing, facial swelling, severe rash, rapid heartbeat. Extremely rare.

Action: Emergency medical care immediately.

Severe Hypoglycemia

Risk: Very low for GLP-1 medications used alone. Risk increases when combined with insulin or sulfonylureas. Patients without diabetes taking GLP-1s for weight loss rarely experience clinically significant hypoglycemia.

The Bigger Picture

Side effects are real, and dismissing them doesn't serve you. But context matters. In clinical trials, discontinuation rates due to adverse events were approximately 4-7% for semaglutide and 4-7% for tirzepatide. That means 93-96% of patients found the side effects manageable enough to continue treatment.

Most side effects are front-loaded — worst during dose escalation, improving with time. And most are manageable with practical strategies rather than medication changes.

At CORAL, Dr. Kim monitors patients throughout their weight loss journey, adjusting doses, managing side effects, and ensuring that the treatment approach works for your body and your life — not just on paper.


Questions about GLP-1 side effects or wondering if weight loss medication is right for you? A consultation can help you weigh the benefits against the realistic side effect profile for your specific situation. [Start your evaluation at coral.clinic/start](https://coral.clinic/start).


Ready to take the next step?

Talk to a real doctor. On your schedule.

Dr. Kim reviews every intake personally. Florida residents can get started online in minutes — no waiting room, no long drives.

Start Weight Loss Intake

Florida residents only · HIPAA-secure · Dr. Kim reviews every case

What do you think?

?
500

Be the first to share your thoughts.

Health tips from Dr. Kim

No spam, just real advice — straight from a physician you can trust.